Clinical Study of Aldurazyme in Patients With Mucopolysaccharidosis (MPS) I

Clinical trial NCT00912925 · COMPLETED

Trial details

NCT number: NCT00912925
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Mucopolysaccharidosis I Hurlers Syndrome Hurler-Scheie Syndrome

Start date: 2000-12-01
Primary completion: 2001-09-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.